Skip to main content
A phase 1B multiple ascending dose study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of a medium chain triglyceride supplement in Alzheimer’s disease
- Author(s): Nygaard, Haakon B;
- Kent, Brianne A;
- Stager, Sam;
- Slack, Penelope;
- DeMarco, Mari L;
- Castellano, Christian‐Alexandre;
- Rauscher, Alexander;
- Cunnane, Stephen;
- Feldman, Howard H
- et al.
Published Web Location
https://alz-journals.onlinelibrary.wiley.com/doi/abs/10.1002/alz.037960No data is associated with this publication.